Endocrine Research Unit, Mayo Clinic and Foundation, Rochester, Minnesota 55905
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Uncoupling protein (UCP)-2 and -3 mediate mitochondrial (mt) proton leak in vitro and are potential
regulators of energy expenditure and ATP production. Aging is
associated with alteration of tissue functions, suggesting impaired
mtATP production. To determine whether age-related changes in UCP
expression occur, we measured the transcript levels of UCP-2 and -3 in
skeletal muscle, liver, and heart in 6- and 27-mo-old rats. UCP-2
transcripts were higher in old animals in the white (+100%) and red
(+70%, both P < 0.04) gastrocnemius muscle and in the
liver (+300%, P < 0.03), whereas they were comparable
in the heart in both age groups. UCP-2 transcript levels correlated
positively with mitochondrial-encoded cytochrome c oxidase
transcripts normalized for mtDNA (P < 0.01) and
negatively with mtDNA copy number (P < 0.001). UCP-3
transcripts were lower in the less oxidative white (50%,
P < 0.04) and unchanged in the more oxidative red
(
15%, P = 0.41) gastrocnemius muscle in old animals.
Similar changes at protein level were confirmed by UCP-2 protein in
aging liver (+300%, P < 0.01) and UCP-2 (+85%, P < 0.05) and UCP-3 (
30%, P = 0.4)
protein in aging mixed gastrocnemius muscle. Aging is thus associated
with tissue-specific changes of UCP-2 and -3 gene expression. Increased
UCP-2 expression may limit ATP production and is related to
mitochondrial gene expression in aging muscles and liver. Different
age-related changes may reflect differential regulation of UCP-2 and -3 in skeletal muscle. The current data suggest a potential role of
uncoupling proteins to alter energy production in aging tissues.
energy metabolism; mitochondria; adenosine 5'-triphosphate; proton leak
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
UNCOUPLING PROTEIN (UCP)-1 produces heat by mediating mitochondrial proton leak in brown adipose tissue and therefore dissipating the electrochemical proton gradient across the inner mitochondrial membrane (7). UCP-2 and -3 are recently discovered members of the mitochondrial uncoupling protein family (8, 17-19, 31, 47) with wider tissue distribution than UCP-1 (8, 17-19, 31, 47). In particular, in both rodents and humans, UCP-2 is expressed in most tissues and organs (17, 31), whereas UCP-3 is mainly expressed in skeletal muscle and adipose tissue (8, 18, 19, 31, 47). Several reports provide indirect (26, 29, 43) and direct (14, 20, 46) evidence of a role of UCP-2 and UCP-3 in the in vivo regulation of energy production and expenditure. Such a role has been elucidated in vitro, where they both mediate mitochondrial proton leak in an identical fashion (25), and their overexpression leads to reductions of mitochondrial membrane potential (18, 19).
Aging is generally associated with a moderate reduction of whole body metabolic rate and energy expenditure in humans (34, 44, 45, 50). Most studies however, agree that resting oxygen consumption is unchanged when normalized for reduced lean body mass (34, 44, 45, 50), and unchanged whole body oxygen consumption has been reported in aging rats (39). In spite of these observations, impaired mitochondrial function and energy production are hypothesized to be involved in age-related alterations of many body functions (22, 48). Aging is associated in both humans (15, 16, 30, 32, 33, 36) and rodents (5, 23) with a decline in skeletal muscle function, including reduced muscle mass and strength and possibly increased muscle fatigability, although available evidence for enhanced fatigability is not conclusive (30, 32, 33, 40). Age-related muscle dysfunction strongly supports reduced ATP availability in this tissue. In vitro studies have shown reduced mitochondrial membrane potential in aging hepatocytes (21), also indicating impaired ability for ATP production and directly suggesting increased uncoupling in the aging liver. On the whole, the above observations suggest that ATP production may be limited by increased uncoupling of oxidative phosphorylation in aging tissues.
In the current study, we have therefore measured UCP-2 and -3 expression in selected tissues in young and old rats. UCP-2 transcript levels were measured in the medial white and the lateral red portions (2) of the gastrocnemius muscle and in the liver, whereas UCP-3 transcripts were measured in both portions of the gastrocnemius. UCP-2 gene expression was also measured in the heart to include a tissue with no apparent age-related changes of in vivo ATP production (28). Liver UCP-2 and mixed gastrocnemius UCP-2 and UCP-3 protein levels were also determined to confirm age-related qualitative changes in gene expression at the protein level.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Animals and experimental protocol.
Young (n = 7, age = 6 mo) and old
(n = 9, age = 27 mo) Fischer 344 male rats were
purchased from the National Institute of Aging. Animal care and all
experiments were carried out in keeping with institutional guidelines
at Mayo Clinic and Foundation. Rats were kept in cages at 22°C under
controlled conditions with a 12:12-h light-dark cycle and consumed a
regular chow diet ad libitum. All animals were anesthetized with an
intraperitoneal overdose of pentobarbital sodium. After achievement of
adequate anesthetic effect, the lateral and medial heads of the
gastrocnemius muscle, liver, and heart were removed quickly in this
order. Tissues were immediately frozen in isopentane, kept in liquid
nitrogen, and stored at 80°C until analysis. These experiments were
performed as part of a protocol designed to study the effects of aging
on mitochondrial gene expression (3).
RNA analysis. cDNA probes for UCP-2 and UCP-3 and 28S rRNA transcripts were generated by RT-PCR amplification from rat skeletal muscle total RNA. Primers for the UCP-2 probe corresponded to nucleotides 467-490 (forward) and 1196-1205 (reverse, PCR product of 746 bp) of the rat UCP-2 sequence (GenBank accession no. AB010743). Primers for the UCP-3 probe corresponded to nucleotides 235-254 (forward) and 980-1003 (reverse, PCR product of 768 bp) of the rat UCP-3 sequence (GenBank accession no. U92069). Primers for the 28S rRNA probe corresponded to nucleotides 4203-4222 (forward) and 4370-4389 (reverse, PCR product 186 bp) of the rat ribosomal RNA genome (GenBank accession no. V01270). Amplification products were cloned into the TA-plasmid vector (TA Cloning kit; Invitrogen), as previously described (3). Total RNA isolation, Northern blotting, and hybridization to UCP-3, UCP-2, and 28S probes (in this order) were performed as described previously (3). Resulting images were quantified by laser densitometry (Ultroscan; Pharmacia), UCP bands were normalized to the corresponding 28S rRNA band, and individual results were expressed as a percentage of the average value for young animals.
Western blot analysis. To confirm changes in UCP-2 and UCP-3 transcripts at the protein level in mitochondria, liver UCP-2 and mixed gastrocnemius UCP-2 and UCP-3 protein levels were measured by Western blot. Tissues for protein determination were selected based on sufficient availability for this additional determination. The mitochondrial protein fraction was isolated from ~50 mg of liver and 100 mg of mixed gastrocnemius muscle by sequential centrifugation as previously described (36). Protein concentration in all samples was measured by a spectrophotometer (BCA Protein Assay Reagent; Pierce, Rockford, IL). Equal amounts of protein (150 µg for liver and 50 µg for each protein for muscle) were then separated on 12% acrylamide gels and transferred to polyvinylidene difluoride membranes (Bio-Rad Laboratories, Hercules, CA). Membranes were hybridized to rabbit antibodies for UCP-2 or UCP-3. Liver samples were hybridized overnight at 4°C to the anti-UCP-2 antibody (AB3226; Chemicon International, Temecula, CA) at a 1:800 dilution. Gastrocnemius muscle samples were hybridized overnight at 4°C to the anti-UCP-2 antibody (Alpha Diagnostic International, San Antonio, TX) at a 1:200 dilution or to the anti-UCP-3 antibody (AB3046; Chemicon International) at a 1:800 dilution at room temperature for 2 h. The secondary antibody for all measurements was peroxidase-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch) used at a 1:20,000 dilution for 1 h at room temperature. Membranes were then exposed to films for 30 min to 3 h (Kodak Biomax MR, Kodak, Rochester, NY), and resulting images were quantified by laser densitometry (Ultroscan; Pharmacia). To ascertain the lack of cross-reactivity of the anti-UCP-3 antibody to UCP-2, liver and skeletal muscle samples were transferred to the same blot in a preliminary experiment and incubated with the anti-UCP-3 antibody by use of the protocol described above. Although the expected signal was detected in skeletal muscle, no bands were detectable in the liver sample, where UCP-3 is not known to be expressed (data not shown). Individual results from all experiments were expressed as a percentage of the average value for young animals. Results were further normalized for mitochondrial protein yield and expressed as UCP-2 and UCP-3 per milligram of tissue to compare them with the transcript levels in the whole tissue and to account for the potential reduction of mitochondrial protein content in aging skeletal muscle and liver.
Statistical analysis. UCP-2 and UCP-3 mRNA or protein levels in young and old animals were compared using an unpaired Student's t-test for the two skeletal muscles, the heart muscle, and liver protein. A nonparametric Wilcoxon test was used to compare UCP-2 transcript levels between young and old animals in the liver. The relationships between UCP mRNA and mitochondrial DNA copy number as well as normalized cytochrome c oxidase I and III mRNA expression from the same animals (3) were analyzed using linear regression analysis. The same analysis was used to study the relationships between UCP mRNA and protein levels in the liver and the gastrocnemius muscle. Results were considered statistically significant at P < 0.05.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
UCP-2 and UCP-3 expression.
UCP-2 transcript levels were higher in old animals in both the lateral
more oxidative and the medial more glycolytic heads of the
gastrocnemius muscle (P < 0.04, Fig.
1A). UCP-2 mRNA levels were
also higher in old animals in the liver (P < 0.03, Fig. 2A), whereas they were
comparable in both age groups in the heart (Fig. 3). At variance with UCP-2, UCP-3 mRNA
levels were lower in the older animals in the white more glycolytic
medial head (P < 0.04), whereas the decrease was
smaller in magnitude (15%) and not statistically significant in the
more oxidative lateral red head of the gastrocnemius muscle (Fig.
4A).
|
|
|
|
Correlations.
Age-related changes in UCP-2 transcript levels mirrored those recently
reported in mitochondrial DNA copy number and were similar to those
observed in mitochondrial DNA-normalized cytochrome c
oxidase I and III transcripts in the same animals (3). We therefore investigated the relationships between these variables in the
different age groups. UCP-2 transcript levels were positively related
to both mitochondrial DNA-normalized cytochrome c oxidase I
(r = 0.51; P < 0.01) and III
(r = 0.50; P < 0.01) in all tissues when all animals were considered together. UCP-2 mRNA expression was
also inversely correlated to mitochondrial DNA copy number in all
tissues (r = 0.51; P < 0.001). These
correlations were confirmed in the aging animals alone (Fig.
5, A-C), whereas they were no
longer present when the young animals were considered separately (Fig.
5, D-F). No correlation was observed between UCP-3 mRNA or
protein and mitochondrial gene expression.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The current study demonstrates that aging is associated with profound tissue-specific alterations of UCP-2 and -3 gene expression in different tissues. UCP-2 mRNA expression is markedly increased in both white and red gastrocnemius muscle and in liver in aging rats. Substantially higher liver and skeletal muscle UCP-2 protein levels in old animals confirm the mRNA data and indicate that similar age-related changes occur for transcript and protein levels. UCP-2 promotes proton leak in vitro (25), and the age-associated increment of its expression therefore suggests increased uncoupling of oxidative phosphorylation in old animals. Increased UCP-2 expression may limit ATP production in aging skeletal muscle and liver, thus representing a novel potential molecular mediator of impaired energy production in the aging process. Although changes of UCP activity with aging are theoretically possible and might partially offset the effects of its increased expression, the current findings are consistent with reduced potential for ATP production suggested by age-related muscle dysfunctions in both human (15, 16, 30, 32, 33, 36) and rodent (5, 23) models and by previous in vitro data directly demonstrating reduced mitochondrial membrane potential in aging hepatocytes (21). At variance with the above findings, no changes were detected in UCP-2 transcript levels in the aging heart. This observation is again in agreement with the preserved cardiac potential for in vivo energy production in aging rats (28), whereas it clearly demonstrates that UCP-2 expression is differentially regulated in aging tissues.
The association of UCP-2 transcripts with relative levels of mitochondrial templates and mitochondrial DNA-normalized cytochrome c oxidase I and III mRNA strongly indicates that the age-associated tissue-specific changes in mitochondrial gene expression (3) are related to and might contribute to changes in UCP-2 expression in these tissues. To our knowledge, these data represent the first observation supporting a coordinated expression of mitochondrial oxidative and nuclear uncoupling protein genes. Of note, parallel increments of uncoupling and mitochondrial oxidative metabolism are a well-described feature of energy metabolism (9, 10, 35, 42), and this obligatory proton leak may account for up to 20% of the basal metabolic rate in rats (35). The unchanged oxygen consumption (34, 39, 44, 45, 50) in the presence of reduced mitochondrial density in aging tissues, including muscle and liver (24, 41), suggests that oxidative metabolism may indeed be enhanced in aging mitochondria. The inverse correlation between UCP-2 and levels of mitochondrial DNA, a possible index of mitochondrial content (3, 24, 41), also suggests that increased UCP-2 expression is related to reduced mitochondrial density with potential increments of mitochondrial oxidative workload in aging tissues. These combined data therefore introduce the possibility that ubiquitously expressed (17, 30) UCP-2 may be a molecular mediator of obligatory proton leak (9, 10, 35, 42). Further in vitro studies are needed to directly address this hypothesis.
The reduced or unchanged UCP-3 transcript levels in the white and red gastrocnemius muscle indicate a differential regulation of UCP-2 and UCP-3 gene expression in aging skeletal muscle. Although average UCP-3 protein levels are not significantly altered by aging in the mixed gastrocnemius, differential changes in transcript levels in the white more glycolytic and red more oxidative portions further suggest that age-related changes in rat skeletal muscle UCP-3 expression may be influenced by muscle fiber composition and metabolic characteristics. Differential changes of UCP-2 and UCP-3 transcripts have previously been related to changes in free fatty acid utilization and turnover in rodents (7). In particular, UCP-3 but not UCP-2 gene expression was enhanced after short-term fasting and fatty acid infusion in rats (49). Muscle UCP-3 expression is not increased in newborn mice until dietary ingestion of fat occurs (11). In human polymorphism studies, UCP-3 mutations have been associated with as much as 50% reductions in basal fat oxidation rates (1), and reduced skeletal muscle UCP-3 but not UCP-2 expression has been reported in people with type 2 diabetes (27). These observations indicate that UCP-3 expression may be directly related to oxidative fuel levels and specifically to muscle mitochondrial fatty acid oxidation (7). The lower UCP-3 mRNA in the aging medial gastrocnemius may therefore suggest impaired fat oxidative disposal in this tissue, as previously reported in aging rat muscles with intermediate oxidative capacity (13, 37). In contrast, however, aging does not appear to affect UCP-3 transcript levels in more oxidative red muscle fibers, which indeed rely more heavily on fatty acid oxidation for energy production (2). Plasma free fatty acid levels were not altered with aging (young = 0.20 ± 0.02 meq/l; old = 0.20 ± 0.02 meq/l). This observation is in agreement with some (12, 38) but not all (4, 6) previous reports on this issue in both rodents and humans. Available data (4, 6, 12, 38) suggest that differential age-related changes of plasma free fatty acid may be related to feeding status, especially to duration of fasting, and to concomitant glucose intolerance in humans. In the current study, differential age effects on UCP-3 expression with preserved UCP-3 transcripts in more oxidative muscles that preferentially utilize free fatty acid are consistent with a lack of major age-related changes in circulating free fatty acid levels. Finally, the combined data from UCP-2 and UCP-3 suggest that net modifications of mitochondrial uncoupling with aging may also be influenced by muscle fiber type. Age-related uncoupling may be more profoundly increased in more oxidative muscle groups with preserved UCP-3 expression, whereas reduced UCP-3 might blunt at least in part the effects of the substantial increase of UCP-2 in highly glycolytic muscles.
In conclusion, the current results demonstrate that aging profoundly modifies UCP-2 and UCP-3 expression in a tissue-specific fashion. Increased UCP-2 transcript and protein levels suggest a novel potential role of increased uncoupling of mitochondrial respiration to limit mitochondrial energy production in aging skeletal muscles and liver. The differential effects of aging on muscle UCP-3 indicate a differential regulation of expression of the two uncoupling proteins in this tissue. In particular, the current data suggest similar regulatory mechanisms of expression of UCP-2 and mitochondrial energy genes, whereas UCP-3 expression may reflect mitochondrial substrate utilization in specific muscle groups.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank J. Kahl, D. Morse, L. Bale, and K. Townsend for skillful technical assistance. We are indebted to Drs. M. Zanetti, K. Kalli, and K. R. Short for helpful comments and suggestions and to Drs. R. Rizza and N. Eberhardt for critical reading of the manuscript.
![]() |
FOOTNOTES |
---|
This work was supported by National Institutes of Health Grants RO AG-09531 and RR-00585.
Address for reprint requests and other correspondence: K. S. Nair, Mayo Clinic-Endocrine Research Unit, Joseph 5-194, Rochester, MN 55905 (E-mail: nair.sree{at}mayo.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 1 May 2000; accepted in final form 31 October 2000.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Argyropulos, G,
Brown AM,
Willi SM,
Zhu J,
He Y,
Reitman M,
Geval SM,
Spruill I,
and
Garvey WT.
Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes.
J Clin Invest
102:
1345-1351,
1998
2.
Armstrong, RB,
and
Phelps RO.
Muscle fiber type composition of the rat hindlimb.
Am J Anat
171:
259-272,
1984[ISI][Medline].
3.
Barazzoni, R,
Short KR,
and
Nair KS.
Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver and heart.
J Biol Chem
275:
3343-3347,
2000
4.
Barzilai, N,
and
Rossetti L.
Relationship between changes in body composition and insulin responsiveness in models of the aging rat.
Am J Physiol Endocrinol Metab
269:
E591-E597,
1995
5.
Blough, ER,
and
Linderman JK.
Lack of skeletal muscle hypertrophy in very aged male Fischer 344 × Brown Norway rats.
J Appl Physiol
88:
1265-1270,
2000
6.
Bonadonna, RC,
Groop LC,
Simonson DC,
and
DeFronzo RA.
Free fatty acid and glucose metabolism in human aging: evidence for operation of the Randle cycle.
Am J Physiol Endocrinol Metab
266:
E501-E509,
1994
7.
Boss, O,
Hagen T,
and
Lowell BB.
Uncoupling proteins 2 and 3. Potential regulators of mitochondrial energy metabolism.
Diabetes
49:
143-156,
2000[Abstract].
8.
Boss, O,
Samec S,
Paoloni-Giacobino A,
Rossier C,
Dulloo AG,
Seydoux J,
Muzzin P,
and
Giacobino JP.
Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression.
FEBS Lett
408:
39-42,
1997[ISI][Medline].
9.
Brand, MD,
Chien L-F,
Ainscow EK,
Rolfe DFS,
and
Porter R.
The causes and function of mitochondrial proton leak.
Biochim Biophys Acta
1187:
132-139,
1994[ISI][Medline].
10.
Brown, GC.
The leaks and slips of bioenergetic membranes.
FASEB J
6:
2961-2965,
1992
11.
Brun, S,
Carmona MC,
Mampel T,
Vinas O,
Giralt M,
Iglesias R,
and
Villaroya F.
Uncoupling protein-3 gene expression in skeletal muscle during development is regulated by nutritional factors that alter circulating non-esterified fatty acids.
FEBS Lett
453:
205-209,
1999[ISI][Medline].
12.
Carlson, LA,
Fröberg SO,
and
Nye ER.
Effect of age on blood and tissue lipid levels in the male rat.
Gerontologia
14:
65-79,
1968[ISI].
13.
Cartee, GD,
and
Farrar RP.
Muscle respiratory capacity and O2 max in identically trained young and old rats.
J Appl Physiol
63:
257-261,
1987
14.
Clapham, JC,
Arch JRS,
Chapman H,
Haynes A,
Lister C,
Moore GBT,
Piercy V,
Carter SA,
Lehner I,
Smith SA,
Beeley LJ,
Godden RJ,
Herrity N,
Skehel M,
Changani KK,
Hockings PD,
Reid DG,
Squires SM,
Hatcher J,
Trail B,
Latcham J,
Rastan S,
Harper AJ,
Cadenas S,
Buckingham JA,
Brand MD,
and
Abuin A.
Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean.
Nature
406:
415-418,
2000[ISI][Medline].
15.
Davies, CTM,
Thomas DO,
and
White MJ.
Mechanical properties of young and elderly human muscle.
Acta Med Scand Suppl
711:
219-226,
1986[Medline].
16.
Evans, WJ.
What is sarcopenia?
J Gerontol A Biol Sci Med Sci
50:
5-8,
1995[ISI][Medline].
17.
Fleury, C,
Neverova M,
Collins S,
Raimbault S,
Champigny O,
Levi-Meyrueis C,
Bouillard F,
Seldin MF,
Surwit RS,
Ricquier D,
and
Warden CH.
Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia.
Nat Genet
15:
269-272,
1997[ISI][Medline].
18.
Gimeno, RE,
Dembski M,
Weng X,
Deng N,
Shyjan AW,
Gimeno CJ,
Iris F,
Ellis SJ,
Woolf EA,
and
Tartaglia LA.
Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis.
Diabetes
46:
900-906,
1997[Abstract].
19.
Gong, D-W,
He Y,
Karas M,
and
Reitman M.
Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin.
J Biol Chem
272:
24129-24132,
1997
20.
Gong, D-W,
Monemdjous S,
Gavrilova O,
Leon LR,
Marcus-Samuels B,
Chou CJ,
Everett C,
Kozak LP,
Li C,
Deng C,
Harper M-E,
and
Reitman ML.
Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3.
J Biol Chem
275:
16251-16257,
2000
21.
Hagen, TM,
Yowe DL,
Bartholomew JC,
Wehr CM,
Do KL,
Park J-Y,
and
Ames BN.
Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase.
Proc Natl Acad Sci USA
94:
3064-3069,
1997
22.
Harman, D.
The aging process.
Proc Natl Acad Sci USA
78:
7124-7128,
1981[Abstract].
23.
Holloszy, JO,
Chen M,
Cartee GD,
and
Young JC.
Skeletal muscle atrophy in old rats: differential changes in the three fiber types.
Mech Ageing Dev
60:
199-213,
1991[ISI][Medline].
24.
Holloszy, JO,
and
Coyle EF.
Adaptations of skeletal muscle to endurance exercise and their metabolic consequences.
J Appl Physiol
56:
831-838,
1984
25.
Jaburek, M,
Varecha M,
Gimeno RE,
Dembski M,
Jezek P,
Zhang M,
Burn P,
Tartaglia LA,
and
Garlid KD.
Transport function and regulation of mitochondrial uncoupling proteins 2 and 3.
J Biol Chem
274:
26003-26007,
1999
26.
Jucker, BM,
Dufour S,
Ren J,
Cao X,
Previs SF,
Underhill B,
Cadman KS,
and
Shulman GI.
Assessment of mitochondrial energy coupling in vivo by 13C/31P NMR.
Proc Natl Acad Sci USA
97:
6880-6884,
2000
27.
Krook, A,
Digby J,
O'Rahilly S,
Zierath JR,
and
Wallberg-Henriksson H.
Uncoupling protein 3 is reduced in skeletal muscle of NIDDM patients.
Diabetes
47:
1528-1531,
1998[Abstract].
28.
Lakatta, EG.
Cardiovascular regulatory mechanisms in advanced age.
Physiol Rev
73:
413-467,
1993
29.
Lanni, A,
De Felice M,
Lombardi A,
Moreno M,
Fleury C,
Ricquier D,
and
Goglia F.
Induction of UCP2 mRNA by thyroid hormones in rat heart.
FEBS Lett
418:
171-174,
1997[ISI][Medline].
30.
Lindström, B,
Lexell J,
Gerdle B,
and
Downham D.
Skeletal muscle fatigue and endurance in young and old men and women.
J Gerontol
52A:
B59-B66,
1997[ISI].
31.
Matsuda, J,
Hosoda K,
Itoh H,
Son C,
Doi K,
Tanaka T,
Fukunaga Y,
Inoue G,
Nishimura H,
Yoshimasa Y,
Yamori Y,
and
Nakao K.
Cloning of rat uncoupling protein-3 and uncoupling protein-2 cDNAs: their gene expression in rats fed high-fat diet.
FEBS Lett
418:
200-204,
1997[ISI][Medline].
32.
McDonagh, MJN,
White MJ,
and
Davies CTM
Different effects of ageing on the mechanical properties of human arm and leg muscles.
Gerontology
30:
49-54,
1984[ISI][Medline].
33.
Narici, MV,
Bordini M,
and
Cerretelli P.
Effect of aging on human adductor pollicis muscle function.
J Appl Physiol
71:
1277-1281,
1991
34.
Poehlman, ET,
McAuliffe TL,
Van Houten DR,
and
Danforth E.
Influence of age and endurance training on metabolic rate and hormones in healthy men.
Am J Physiol Endocrinol Metab
259:
E66-E72,
1990
35.
Rolfe, DFS,
Hulbert AJ,
and
Brand MD.
Characteristics of mitochondrial proton leak and control of oxidative phosphorylation in the major oxygen consuming tissues of the rat.
Biochim Biophys Acta
1118:
405-416,
1994.
36.
Rooyakers, O,
Adey DB,
Ades PA,
and
Nair KS.
Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle.
Proc Natl Acad Sci USA
93:
15364-15369,
1996
37.
Rumsey, WL,
Kendrick ZV,
and
Starnes JW.
Bioenergetics in the aging Fischer 344 rat: effects of exercise and food restriction.
Exp Gerontol
22:
271-287,
1987[ISI][Medline].
38.
Sandberg, HN,
Yoshimine N,
Maeda S,
Symons D,
and
Zavodnick J.
Effects of an oral glucose load on serum immunoreactive insulin, free fatty acid, growth hormone and blood sugar levels in young and elderly subjects.
J Am Geriatr Soc
21:
433-439,
1973[ISI][Medline].
39.
Scarpace, PJ,
Matheny M,
Moore RL,
and
Tumer N.
Impaired leptin responsiveness in aging rats.
Diabetes
49:
431-435,
2000[Abstract].
40.
Schwendner, KI,
Mikesky AE,
Holt WS, Jr,
Peacock M,
and
Burr DB.
Differences in muscle endurance and recovery between fallers and nonfallers, and between young and older women.
J Gerontol
52A:
M155-M160,
1997[ISI].
41.
Scotto, AW,
Rineheart RW,
and
Beattie DS.
Aging-related decreases in hepatic mitochondrial and cytosolic delta-aminolevulinic acid synthase during experimental porphyria.
Arch Biochem Biophys
222:
150-157,
1983[ISI][Medline].
42.
Skulachev, VP.
Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants.
Q Rev Biophys
29:
169-202,
1996[ISI][Medline].
43.
Surwit, RS,
Wang S,
Petro AE,
Sanchis D,
Raimbault S,
Ricquier D,
and
Collins S.
Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice.
Proc Natl Acad Sci USA
95:
4061-4065,
1998
44.
Tzankoff, SP,
and
Norris AH.
Effect of muscle mass decrease on age-related BMR changes.
J Appl Physiol
43:
1001-1006,
1977
45.
Tzankoff, SP,
and
Norris AH.
Longitudinal changes in basal metabolism in man.
J Appl Physiol
45:
536-539,
1978
46.
Vidal-Puig, AJ,
Grujic D,
Zhang C-Y,
Hagen T,
Boss O,
Ido Y,
Szczepanik A,
Wade J,
Mootha V,
Cortright R,
Muoio DM,
and
Lowell BB.
Energy metabolism in uncoupling protein 3 gene knockout mice.
J Biol Chem
275:
16258-16266,
2000
47.
Vidal-Puig, A,
Solanes G,
Grujic D,
Flier JS,
and
Lowell BB.
UCP-3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue.
Biochem Biophys Res Commun
235:
79-82,
1997[ISI][Medline].
48.
Wallace, DC.
Mitochondrial genetics: a paradigm for aging and degenerative diseases?
Science
256:
628-632,
1992[ISI][Medline].
49.
Weigle, DS,
Selfridge LE,
Schwartz MW,
Seeley RJ,
Cummings DE,
Havel PJ,
Kuijper JL,
and
BeltrandelRio H.
Elevated free fatty acids induce uncoupling protein 3 expression in muscle: a potential explanation for the effect of fasting.
Diabetes
47:
298-302,
1998[Abstract].
50.
Welle, S,
Thornton C,
Totterman S,
and
Forbes G.
Utility of creatinine excretion in body-composition studies of healthy men and women older than 60 y.
Am J Clin Nutr
63:
151-156,
1996[Abstract].